Genscript Biotech Corporation
GNNSF News Today: Stay Updated with the Latest Genscript Biotech Corporation News in Real Time
Find GNNSF news now at Meyka AI. Stay informed with the latest Genscript Biotech Corporation stocks updates, including price news, market analysis, and expert insights.

XtalPi Holdings Ltd Slips 3.3% as AI Drug Discovery Faces Valuation Pressure
2228.HK stock drops 3.3% to HK$7.9 amid sector headwinds. XtalPi Holdings faces valuation challenges despite AI-driven drug discovery focus.

T-Gaia Corporation (3738.T) Holds Steady at ¥2,659 Amid Volume Surge
3738.T stock trades flat at ¥2,659 on JPX with volume spike to 157,000 shares. Meyka AI rates the telecom distributor with a B- grade.

Radha Madhav Corporation Surges 9,900% as RMCL.BO Hits ₹195
RMCL.BO stock surges 9,900% to ₹195 on BSE. Radha Madhav packaging firm shows extreme volatility in high-volume trading session.

Genocea Biosciences Stock Collapses 97% as Bankruptcy Restructuring Continues
GNCA stock plummets 97.44% to $0.0001 after Chapter 11 bankruptcy filing. Biotech firm restructures cancer immunotherapy pipeline.

With us Corporation Stock Holds at ¥3,225 Amid Oversold Bounce
9696.T stock trades flat at ¥3,225 on JPX. Education services firm shows mixed fundamentals with B+ Meyka grade and strong long-term gains.

Vibe Growth Corporation Stock Plummets 40% on Weak Fundamentals
VIBE.CN stock crashes 40% to C$0.30 as cannabis retailer faces profitability challenges and negative earnings outlook.

Pacific Edge Limited (PEB.AX) Slips 2.1% as Earnings Loom
PEB.AX stock falls 2.1% to A$0.23 ahead of May 24 earnings announcement. Cancer diagnostics firm faces profitability challenges.

Atrium Mortgage Investment Corporation (AI.TO) Climbs 0.51% on Steady Dividend Yield
AI.TO stock rises 0.51% to C$11.76 with 8.86% dividend yield. Non-bank lender trades near 50-day average amid mortgage market activity.

ICCC ImmuCell CEO Stock Option Filing May 20, 2026
ImmuCell CEO te Boekhorst files non-qualified stock option grant worth $149,441. Form 3 filing reveals 25,329 shares at $5.90 strike price.